insights_auto
Why is GUTS down 3.47%?
Dive Deeperchevron_right
GUTS:NASDAQ
Fractyl Health Inc
$0.94
arrow_downward
-3.47%(-0.034) 1D
$0.94
arrow_downward
-0.28% (-0.0026)todayPre-market
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUTS...
Open
$1.00
High
$1.00
Low
$0.92
Mkt. cap
12.46M
Avg. vol.
1.63M
Volume
1.96K
52-wk high
$29.34
52-wk low
$0.82
EPS
-$13.43
Shares outstanding
13.26M
No. of employees
100
Open
$1.00
High
$1.00
Low
$0.92
Mkt. cap
12.46M
Avg. vol.
1.63M
Volume
1.96K
52-wk high
$29.34
52-wk low
$0.82
EPS
-$13.43
Shares outstanding
13.26M
No. of employees
100
News stories
From web sources and news partners
FinancialContent
·
1 hour ago
Yum China (NYSE:YUMC) misses Q3 2026 sales expectations
The Motley Fool
·
25 minutes ago
The S&P 500's Record Profits Are Hiding a Problem Investors Haven't Seen Before
Barchart.com
·
14 minutes ago
Nasdaq Futures Climb as Chip Stocks Rebound; U.S. Midterms in Focus
Barron's
·
1 hour ago
Stocks That Explain Today’s Market
Profile
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1. Wikipedia
About Fractyl Health Inc
CEO-
Employees100
Founded2010
HeadquartersBurlington, Massachusetts, United States
SectorMedical device
Websitefractyl.com